LIA
ELV icon

LS Investment Advisors’s Elevance Health ELV Stock Holding History

LS Investment Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,767
Closed -$970K – 130
2025
Q4 		$970K Sell
2,767
-383
-12% -$129K 0.14% 83
2025
Q3 		$1.02M Buy
+3,150
New +$980K 0.14% 78
2024
Q4 		– Sell
-5,837
Closed -$3.04M – 137
2024
Q3 		$3.04M Buy
5,837
+63
+1% +$33.7K 0.45% 45
2024
Q2 		$3.13M Buy
5,774
+933
+19% +$493K 0.49% 43
2024
Q1 		$2.51M Buy
4,841
+3,771
+352% +$1.88M 0.4% 51
2023
Q4 		$505K Buy
+1,070
New +$495K 0.09% 103
2023
Q2 		– Sell
-1,315
Closed -$605K – 126
2023
Q1 		$605K Buy
1,315
+375
+40% +$178K 0.11% 85
2022
Q4 		$482K Buy
+940
New +$477K 0.09% 96
2021
Q2 		– Sell
-8,937
Closed -$3.21M – 331
2021
Q1 		$3.21M Sell
8,937
-568
-6% -$183K 0.18% 130
2020
Q4 		$3.05M Sell
9,505
-267
-3% -$81.9K 0.16% 134
2020
Q3 		$2.63M Buy
9,772
+197
+2% +$53K 0.15% 140
2020
Q2 		$2.52M Sell
9,575
-151
-2% -$40.3K 0.16% 140
2020
Q1 		$2.21M Sell
9,726
-616
-6% -$168K 0.16% 139
2019
Q4 		$3.12M Buy
10,342
+118
+1% +$32.5K 0.17% 125
2019
Q3 		$2.46M Buy
10,224
+303
+3% +$83K 0.14% 149
2019
Q2 		$2.8M Buy
9,921
+103
+1% +$28.1K 0.17% 128
2019
Q1 		$2.82M Buy
9,818
+70
+0.7% +$20.2K 0.18% 126
2018
Q4 		$2.56M Buy
9,748
+105
+1% +$28.9K 0.18% 126
2018
Q3 		$2.64M Sell
9,643
-244
-2% -$63.3K 0.15% 138
2018
Q2 		$2.35M Sell
9,887
-240
-2% -$55.6K 0.14% 152
2018
Q1 		$2.23M Sell
10,127
-363
-3% -$85.3K 0.13% 160
2017
Q4 		$2.36M Sell
10,490
-544
-5% -$116K 0.14% 150
2017
Q3 		$2.1M Buy
11,034
+100
+0.9% +$19K 0.12% 161
2017
Q2 		$2.06M Buy
10,934
+56
+0.5% +$10.1K 0.13% 164
2017
Q1 		$1.8M Buy
10,878
+498
+5% +$79.2K 0.12% 176
2016
Q4 		$1.49M Buy
10,380
+536
+5% +$71.8K 0.11% 199
2016
Q3 		$1.23M Sell
9,844
-1,261
-11% -$163K 0.09% 212
2016
Q2 		$1.46M Buy
11,105
+786
+8% +$108K 0.1% 203
2016
Q1 		$1.43M Buy
10,319
+168
+2% +$22.4K 0.11% 199
2015
Q4 		$1.42M Buy
10,151
+632
+7% +$87.1K 0.11% 189
2015
Q3 		$1.33M Buy
9,519
+219
+2% +$32.9K 0.11% 197
2015
Q2 		$1.53M Buy
9,300
+265
+3% +$42.3K 0.11% 188
2015
Q1 		$1.4M Buy
9,035
+1,808
+25% +$257K 0.11% 198
2014
Q4 		$908K Sell
7,227
-418
-5% -$51.7K 0.07% 220
2014
Q3 		$914K Sell
7,645
-265
-3% -$30.4K 0.08% 207
2014
Q2 		$851K Sell
7,910
-213
-3% -$21.9K 0.07% 216
2014
Q1 		$809K Buy
8,123
+4,523
+126% +$409K 0.07% 221
2013
Q4 		$333K Buy
3,600
+1,019
+39% +$90.5K 0.03% 305
2013
Q3 		$216K Buy
2,581
+340
+15% +$29.1K 0.03% 234
2013
Q2 		$183K Buy
+2,241
New +$168K 0.02% 232

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

LS Investment Advisors's ELV Position: Q1 2026 in Review

LS Investment Advisors sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 2,767 shares — an estimated $970K sold.

LS Investment Advisors first reported a position in ELV in Q2 2013 and held it in 40 quarters. The position peaked at $3.21M in Q1 2021. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • LS Investment Advisors reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • LS Investment Advisors sold 2,767 Elevance Health shares in Q1 2026, an estimated $970K.
  • LS Investment Advisors first reported a position in Elevance Health in Q2 2013 and held it in 40 quarters.
  • LS Investment Advisors's Elevance Health position peaked at $3.21M in Q1 2021.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on LS Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.